Chemistry and biology of angiitis inducer, Candida albicans water-soluble mannoprotein-β-glucan complex (CAWS)

Microbiology and Immunology

Volumn 47, Issue 7, 2003, Pages 479-490

  Ohno, Naohito ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Angiitis; Candida albicans; CAWS; Glucan

Indexed keywords

BETA GLUCAN; CANDIDA ALBICANS WATER SOLUBLE MANNOPROTEIN BETA GLUCAN COMPLEX; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; SCHIZOPHYLLAN; UNCLASSIFIED DRUG;

ARTERITIS; BIOCHEMISTRY; CANDIDA ALBICANS; CARBOHYDRATE ANALYSIS; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DRUG SENSITIVITY; HALF LIFE TIME; IMMUNOCHEMISTRY; LABORATORY TEST; LETHALITY; LEUKOCYTE; LIMULUS G TEST; MYCOSIS; NONHUMAN; SCREENING; SHORT SURVEY; THROMBOCYTE AGGREGATION; TISSUE DISTRIBUTION; VASCULITIS;

CANDIDA; CANDIDA ALBICANS; LIMULUS;

EID: 0041309871     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2003.tb03409.x     Document Type: Short Survey

References (61)

1. Adachi, Y., Ohno, N., Ohsawa, M., Oikawa, S., and Yadomae, T. 1990. Change of biological activities of (1→3)-beta-D-glucan from Grifola frondosa upon molecular weight reduction by heat treatment. Chem. Pharm. Bull. (Tokyo) 38: 477-481.
2. Aketagawa, J., Tanaka, S., Tamura, H., Shibata, Y., and Saito, H. 1993. Activation of limulus coagulation factor G by several (1→3)-beta-D-glucans: comparison of the potency of glucans with identical degree of polymerization but different conformations. J. Biochem. (Tokyo) 113: 683-686.
3. Barron, K.S. 2002. Kawasaki disease: etiology, pathogenesis, and treatment. Cleve. Clin. J. Med. 69 (Suppl 2): SII69-78.
4. Chaffin, W.L., Lopez Ribot, J.L., Casanova, M., Gozalbo, D., and Martinez, J.P. 1998. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol. Mol. Biol. Rev. 62: 130-180.
5. Fleet, G.H. 1985. Composition and structure of yeast cell walls. Curr. Top. Med. Mycol. 1: 24-56.
6. Fukazawa, Y., Kagaya, K., and Shinoda, T. 1995. Cell wall polysaccharides of pathogenic yeasts. Curr. Top. Med. Mycol. 6: 189-219.
7. Hirao, J., Hibi, S., Andoh, T., and Ichimura, T. 1997. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int. Arch. Allergy Immunol. 112: 152-156.
8. Ishida Okawara, A., Oharaseki, T., Takahashi, K., Hashimoto, Y., Aratani, Y., Koyama, H., Maeda, N., Naoe, S., and Suzuki, K. 2001. Contribution of myeloperoxidase to coronary artery vasculitis associated with MPO-ANCA production. Inflammation 25: 381-387.
9. Jennette, J.C. 2002. Implications for pathogenesis of patterns of injury in small- and medium-sized-vessel vasculitis. Cleve. Clin. J. Med. 69 (Suppl 2): SII33-38.
10. Kawasaki, T. 2002. [History of cardiology in the last 100 years: Japanese contribution to studies on Kawasaki disease] Nippon Naika Gakkai Zasshi 91: 838-840.
11. Kikuchi, T., Ohno, N., and Ohno, T. 2002. Maturation of dendritic cells induced by Candida beta-D-glucan. Int. Immunopharmacol. 2: 1503-1508.
12. Kim, D.S., Lee, H.K., Noh, G.W., Lee, S.I., and Lee, K.Y. 1996. Increased serum interleukin-10 level in Kawasaki disease. Yonsei Med. J. 37: 125-130.
13. Kitajima, Y. 2000. [Structural and biochemical characteristics of pathogenic fungus: cell walls, lipids and dimorphism, and action modes of antifungal agents] Nippon Ishinkin Gakkai Zasshi 41: 211-217.
14. Kobayashi, H., Tanaka, S., Suzuki, J., Kiuchi, Y., Shibata, N., Suzuki, S., and Okawa, Y. 1997. Amended structure of side chains in a cell wall mannan from Candida albicans serotype A strain grown in yeast extract-Sabouraud liquid medium under acidic conditions: detection of the branched side chains corresponding to antigenic factor 4. FEMS Microbiol. Lett. 152: 235-242.
15. Kottom, T.J., and Limper, A.H. 2000. Cell wall assembly by Pneumocystis carinii. Evidence for a unique gsc-1 subunit mediating beta-1,3-glucan deposition. J. Biol. Chem. 275: 40628-40634.
16. Kurihara, K., Miura, N.N., Uchiyama, M., Ohno, N., Adachi, Y., Aizawa, M., Tamura, H., Tanaka, S., and Yadomae, T. 2000. Measurement of blood clearance time by Limulus G test of Candida-water soluble polysaccharide fraction, CAWS, in mice. FEMS Immunol. Med. Microbiol. 29: 69-76.
17. Kurihara, K., Shingo, Y., Miura, N.N., Horie, S., Usui, Y., Adachi, Y., Yadomae, T., and Ohno, N. 2003. Effect of CAWS, a mannoprotein-beta-glucan complex of Candida albicans, on leukocyte, endothelial cell, and platelet functions in vitro. Biol. Pharm. Bull. 26: 233-240.
18. Martinez, J.P., and Gozalbo, D. 1994. Chitin synthetases in Candida albicans: a review on their subcellular distribution and biological function. Microbiologia 10: 239-248.
19. Matsumoto, Y., Matsuda, S., and Tegoshi, T. 1989. Yeast glucan in the cyst wall of Pneumocystis carinii. J. Protozool. 36: 21S-22S.
20. Miura, N.N., Miura, T., Ohno, N., Adachi, Y., Watanabe, M., Tamura, H., Tanaka, S., and Yadomae, T. 1998. Gradual solubilization of Candida cell wall beta-glucan by oxidative degradation in mice. FEMS Immunol. Med. Microbiol. 21: 123-129.
21. Miura, N.N., Ohno, N., Aketagawa, J., Tamura, H., Tanaka, S., and Yadomae, T. 1996. Blood clearance of (1→3)-beta-D-glucan in MRL lpr/lpr mice. FEMS Immunol. Med. Microbiol. 13: 51-57.
22. Moriya, K., Miura, N.N., Adachi, Y., and Ohno, N. 2002. Systemic inflammatory response associated with augmentation and activation of leukocytes in Candida/indomethacin administered mice. Biol. Pharm. Bull. 25: 816-822.
23. Mura, N.N., Ohno, N., Adachi, Y., Aketagawa, J., Tamura, H., Tanaka, S., and Yadomae, T. 1995. Comparison of the blood clearance of triple- and single-helical schizophyllan in mice. Biol. Pharm. Bull. 18: 185-189.
24. Murata, H., Iijima, H., Naoe, S., Atobe, T., Uchiyama, T., and Arakawa, S. 1987. The pathogenesis of experimental arteritis induced by Candida alkali-extract in mice. Jpn. J. Exp. Med. 57: 305-313.
25. Murata, H., and Naoe, S. 1987. Experimental Candida-induced arteritis in mice-relation to arteritis in Kawasaki disease. Prog. Clin. Biol. Res. 250: 523.
26. Nagi, N., Ohno, N., Adachi, Y., Aketagawa, J., Tamura, H., Shibata, Y., Tanaka, S., and Yadomae, T. 1993. Application of limulus test (G pathway) for the detection of different conformers of (1→3)-beta-D-glucans. Biol. Pharm. Bull. 16: 822-828.
27. Nakagawa, Y., Ohno, N., and Murai, T. 2003. Suppression by Candida albicans beta-glucan of cytokine release from activated human monocytes and from T cells in the presence of monocytes. J. Infect. Dis. 187: 710-713.
28. Noh, G.W., Lee, W.G., Lee, W., and Lee, K. 1998. Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease. Immunol. Lett. 62: 19-24.
29. Obayashi, T. 1990. A new endotoxin-specific assay. Adv. Exp. Med. Biol. 256: 215-223.
30. Obayashi, T., Tamura, H., Tanaka, S., Ohki, M., Takahashi, S., Arai, M., Masuda, M., and Kawai, T. 1985. A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin. Chim. Acta 149: 55-65.
31. Obayashi, T., Yoshida, M., Mori, T., Goto, H., Yasuoka, A., Iwasaki, H., Teshima, H., Kohno, S., Horiuchi, A., Ito, A., et al. 1995. Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345: 17-20.
32. Obayashi, T., Yoshida, M., Tamura, H., Aketagawa, J., Tanaka, S., and Kawai, T. 1992. Determination of plasma (1→3)-beta-D-glucan: a new diagnostic aid to deep mycosis. J. Med. Vet. Mycol. 30: 275-280.
33. Ohno, N., Hashimoto, T., Adachi, Y., and Yadomae, T. 1996. Conformation dependency of nitric oxide synthesis of murine peritoneal macrophages by beta-glucans in vitro. Immunol. Lett. 52: 1-7.
34. Ohno, N., Uchiyama, M., Tsuzuki, A., Tokunaka, K., Miura, N.N., Adachi, Y., Aizawa, M.W., Tamura, H., Tanaka, S., and Yadomae, T. 1999. Solubilization of yeast cell-wall beta-(1→3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. Carbohydr. Res. 316: 161-172.
35. Osumi, M. 1998. The ultrastructure of yeast: cell wall structure and formation. Micron 29: 207-233.
36. Pinderski, L.J., Fischbein, M.P., Subbanagounder, G., Fishbein, M.C., Kubo, N., Cheroutre, H., Curtiss, L.K., Berliner, J.A., and Boisvert, W.A. 2002. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ. Res. 90: 1064-1071.
37. Pinderski Oslund, L.J., Hedrick, C.C., Olvera, T., Hagenbaugh, A., Territo, M., Berliner, J.A., and Fyfe, A.I. 1999. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 19: 2847-2853.
38. Raisanen Sokolowski, A., Glysing Jensen, T., and Russell, M.E. 1998. Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice. Am. J. Pathol. 153: 1491-1500.
39. Saito, H., Yoshioka, Y., Uehara, N., Aketagawa, J., Tanaka, S., and Shibata, Y. 1991. Relationship between conformation and biological response for (1→3)-beta-D-glucans in the activation of coagulation factor G from limulus amebocyte lysate and host-mediated antitumor activity. Demonstration of single-helix conformation as a stimulant. Carbohydr. Res. 217: 181-190.
40. Saito, K., Nishijima, M., Ohno, N., Yadomae, T., and Miyazaki, T. 1992. Structure and antitumor activity of the less-branched derivatives of an alkali-soluble glucan isolated from Omphalia lapidescens (Studies on fungal polysaccharide. XXXVIII). Chem. Pharm. Bull. (Tokyo) 40: 261-263.
41. Shepherd, M.G. 1987. Cell envelope of Candida albicans. Crit. Rev. Microbiol. 15: 7-25.
42. Shibata, N., Onozawa, M., Tadano, N., Hinosawa, Y., Suzuki, A., Ikuta, K., Kobayashi, H., Suzuki, S., and Okawa, Y. 1996. Structure and antigenicity of the mannans of Candida famata and Candida saitoana: comparative study with the mannan of Candida guilliermondii. Arch. Biochem. Biophys. 336: 49-58.
43. Suda, M., Ohno, N., Hashimoto, T., Koizumi, K., Adachi, Y., and Yadomae, T. 1996. Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1→3)-beta-D-glucan, SSG, in mice. FEMS Immunol. Med. Microbiol. 15: 93-100.
44. Suzuki, K. 2001. Neutrophil functions of patients with vasculitis related to myeloperoxidase-specific anti-neutrophil antibody. Int. J. Hematol. 74: 134-143.
45. Suzuki, S. 1997. Immunochemical study on mannans of genus Candida. I. Structural investigation of antigenic factors 1, 4, 5, 6, 8, 9, 11, 13, 13b and 34. Curr. Top. Med. Mycol. 8: 57-70.
46. Takahashi, H., Ohno, N., Adachi, Y., and Yadomae, T. 2001 Association of immunological disorders in lethal side effect of NSAIDs on beta-glucan-administered mice. FEMS Immunol. Med. Microbiol. 31: 1-14.
47. Tamura, H., Tanaka, S., Ikeda, T., Obayashi, T., and Hashimoto, Y. 1997. Plasma (1→3)-beta-D-glucan assay and immunohistochemical staining of (1→3)-beta-D-glucan in the fungal cell walls using a novel horseshoe crab protein (T-GBP) that specifically binds to (1→3)-beta-D-glucan. J. Clin. Lab. Anal. 11: 104-109.
48. Tanaka, S., Aketagawa, J., Takahashi, S., Shibata, Y., Tsumuraya, Y., and Hashimoto, Y. 1993. Inhibition of high-molecular-weight-(1→3)-beta-D-glucan-dependent activation of a limulus coagulation factor G by laminaran oligosaccharides and curdlan degradation products. Carbohydr. Res. 244: 115-127.
49. Tokunaka, K., Ohno, N., Adachi, Y., Miura, N.N., and Yadomae, T. 2002. Application of Candida solubilized cell wall beta-glucan in antitumor immunotherapy against P815 mastocytoma in mice. Int. Immunopharmacol. 2: 59-67.
50. Tokunaka, K., Ohno, N., Adachi, Y., Tanaka, S., Tamura, H., and Yadomae, T. 2000. Immunopharmacological and immunotoxicological activities of a water-soluble (1→3)-beta-D-glucan, CSBG from Candida spp. Int. J. Immunopharmacol. 22: 383-394.
51. Tse, S.M., Silverman, E.D., McCrindle, B.W., and Yeung, R.S. 2002. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J. Pediatr. 140: 450-455.
52. Uchiyama, M., Ohno, N., Miura, N.N., Adachi, Y., Aizawa, M.W., Tamura, H., Tanaka, S., and Yadomae, T. 1999. Chemical and immunochemical characterization of limulus factor G-activating substance of Candida spp. FEMS Immunol. Med. Microbiol. 24: 411-420.
53. Uchiyama, M., Ohno, N., Miura, N.N., Adachi, Y., Tamura, H., Tanaka, S., and Yadomae, T. 2000. Solubilized cell wall beta-glucan, CSBG, is an epitope of Candida immune mice. Biol. Pharm. Bull. 23: 672-676.
54. Vassallo, R., Standing, J., and Limper, A.H. 1999. Beta-glucan from Pneumocystis carinii stimulates TNF alpha release from alveolar macrophages. J. Eukaryot. Microbiol. 46: I45S.
55. Yadomae, T. 2000. [Structure and biological activities of fungal beta-1,3-glucans] Yakugaku Zasshi 120: 413-431.
56. Yasuoka, A., Tachikawa, N., Shimada, K., Kimura, S., and Oka, S. 1996. (1→3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia. Clin. Diagn. Lab. Immunol. 3: 197-199.
57. Yoshida, M. 2001. [Monitoring and prophylaxis] Nippon Ishinkin Gakkai Zasshi 42: 205-210.
58. Yoshida, M., Obayashi, T., Iwama, A., Ito, M., Tsunoda, S., Suzuki, T., Muroi, K., Ohta, M., Sakamoto, S., and Miura, Y. 1997. Detection of plasma (1→3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J. Med. Vet. Mycol. 35: 371-374.
59. Yoshida, M., Roth, R.I., Grunfeld, C., Feingold, K.R., and Levin, J. 1996. Soluble (1→3)-beta-D-glucan purified from Candida albicans: biologic effects and distribution in blood and organs in rabbits. J. Lab. Clin. Med. 128: 103-114.
60. Yoshida, M., Tsubaki, K., Kobayashi, T., Tanimoto, M., Kuriyama, K., Murakami, H., Minami, S., Hiraoka, A., Takahashi, I., Naoe, T., Asou, N., Kageyama, S., Tomonaga, M., Saito, H., and Ohno, R. 1999. Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991. Int. J. Hematol. 70: 261-267.
61. Yoshioka, S., Ohno, N., Miura, T., Adachi, Y., and Yadomae, T. 1998. Immunotoxicity of soluble beta-glucans induced by indomethacin treatment. FEMS Immunol. Med. Microbiol. 21: 171-179.